CLINICAL_TRIALS
research
· 2011-08-04
Clinical Trial Update: Safety Profile of Insulin Like Growth Factor-1 (IGF-I) Administration in Adolescents [Phase 1, Phase 2]
Summary
A clinical trial update reports safety data on IGF-1 administration in adolescents with anorexia nervosa (Phase 1/2).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Anorexia Nervosa | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2011-08-04